Treatment of atopic dermatitis using topical antifungal drugs: A meta‐analysis-Reference-Cited by-同舟云学术

Treatment of atopic dermatitis using topical antifungal drugs: A meta‐analysis

Published:2022-10-27 Issue:12 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

He Dan¹,Han Yujie¹,Wu Hongmei¹²,Liu Min¹,Li Mao³,Lu Mao¹³

Affiliation:

1. School of Clinical Medicine Chengdu Medical College Chengdu Sichuan China

2. Department of Dermatovenereology Neijiang Second People's Hospital Neijiang Sichuan China

3. Department of Dermatovenereology The First Affiliated Hospital of Chengdu Medical College Chengdu Sichuan China

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15930

Reference30 articles.

1. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects

2. Anti‐Malassezia‐specific IgE antibodies production in Japanese patients with head and neck atopic dermatitis: relationship between the level of specific IgE antibody and the colonization frequency of cutaneous Malassezia species and clinical severity;Zhang E;J Allergy (Cairo),2011

3. Head and Neck Atopic Dermatitis and Malassezia-furfur-Specific IgE Antibodies

4. The Role of Fungi in Atopic Dermatitis

5. Comparison of sertaconazole 2% cream versus hydrocortisone 1% ointment in the treatment of atopic dermatitis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the skin microbiome in atopic dermatitis pathogenesis and disease modification;Journal of Allergy and Clinical Immunology;2024-07

2. Advancements in the application of natural extracts for atopic dermatitis treatment;Journal of Dermatologic Science and Cosmetic Technology;2024-06

3. Decreased skin colonization with Malassezia spp. and increased skin colonization with Candida spp. in patients with severe atopic dermatitis;Frontiers in Medicine;2024-02-20

4. Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adolescents and adults: pooled results from 2 phase 3 studies;Journal of Dermatological Treatment;2024-01-31